Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
ID06038331

Evaluation of a Sterile Umbilical Cord Amniotic Membrane Implant for Symptomatic Scaphotrapeziotrapezoidal Osteoarthritis

Led by TBF Genie Tissulaire · Updated on 2025-09-30

14

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a sterile, processed umbilical cord amniotic membrane implant to treat scaphotrapeziotrapezoidal (STT) osteoarthritis, a condition causing joint pain and dysfunction in the hand. This open, prospective, multicenter trial aims to assess the implant's effect on reducing symptoms related to STT osteoarthritis over one year. The study is sponsored by TBF Genie Tissulaire and takes place within a Phase 2 clinical research framework. Participants receive the SclerFIX-IP implant, which is a decellularized, viro-inactivated, freeze-dried, sterile graft made from the amniotic membrane of the umbilical cord. This graft is placed in joint interposition at the STT joint to potentially improve joint function and reduce pain. The treatment is delivered as a surgical implant. There is no masking or blinding involved in this study. During the 12-month follow-up, participants will be monitored for symptom improvement, including pain reduction, functional activity improvement involving the thumb, and increased thumb and grip strength. Researchers will also assess the absence of inflammatory reactions and the implant's local tolerance. Safety is evaluated by checking for any joint space anomalies. Participants will have regular assessments at 1, 3, 6, and 12 months to track these outcomes.

CONDITIONS

Brief Title

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female aged between 18 and 75 years
  • Patient with symptomatic STT osteoarthritis
  • Patient treated medically for functional symptoms for more than 3 months without improvement
  • QuickDash score greater than 33 points (converted to 50%)
  • Wrist pain in front of the STT joint at rest rated 4 or higher on a 10-point scale
  • Provided informed consent after receiving study information
  • Member or beneficiary of a national health insurance plan
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women or women without effective contraception
  • Patient with functional rhizarthrosis not stabilized or treated medically or surgically
  • Patient with signs of neuropathy causing functional disorders such as hyperesthesia
  • Patient with uncontrolled epilepsy or neuropathy contraindicating locoregional anesthesia
  • Person confined by judicial or administrative decision
  • Adult under legal protection or unable to provide consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - 12 months

Participants receive an implant of a treated, devitalized, and sterile umbilical cord amniotic membrane in the scaphotrapeziotrapezoidal joint to treat osteoarthritis symptoms.

Visits at 1 month, 3 months, 6 months, and 12 months

Trial Site Locations

Total: 4 locations

1

CHU de Besançon

Besançon, France, 25030

Actively Recruiting

2

Institut Chirurgical de la Main et du Membre Supérieur (ICMMS)

Lyon, France, 69006

Actively Recruiting

3

Centre de la Main - Clinique Jules Verne

Nantes, France, 44300

Actively Recruiting

4

Hôpitaux Universitaires de Strasbourg

Strasbourg, France, 67200

Actively Recruiting

Loading map...

Research Team

L

Laurence BARNOUIN, MD

J

Justine BOSC, MSc

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Migration of the CapFlex-PIP Implant System for Proximal Int...

Osteoarthritis Hand

Actively Recruiting

1 location

Capsaicin in Digital Osteoarthritis Versus Control: a Random...

Osteoarthritis Hand

Actively Recruiting

4 locations

Assessment of Cardiovascular Risk in Digital Osteoarthritis:...

Osteoarthritis Hand

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here